Literature DB >> 25890205

Lighting up G protein-coupled purinergic receptors with engineered fluorescent ligands.

Francisco Ciruela1, Víctor Fernández-Dueñas2, Kenneth A Jacobson3.   

Abstract

The use of G protein-coupled receptors fluorescent ligands is undergoing continuous expansion. In line with this, fluorescent agonists and antagonists of high affinity for G protein-coupled adenosine and P2Y receptors have been shown to be useful pharmacological probe compounds. Fluorescent ligands for A1R, A2AR, and A3R (adenosine receptors) and P2Y2R, P2Y4R, P2Y6R, and P2Y14R (nucleotide receptors) have been reported. Such ligands have been successfully applied to drug discovery and to GPCR characterization by flow cytometry, fluorescence correlation spectroscopy, fluorescence microscopy, fluorescence polarization, fluorescence resonance energy transfer and scanning confocal microscopy. Here we summarize recently reported and readily available representative fluorescent ligands of purinergic receptors. In addition, we pay special attention on the use of this family of fluorescent ligands revealing two main aspects of purinergic receptor biology, namely ligand binding and receptor oligomerization. This article is part of the Special Issue entitled 'Fluorescent Tools in Neuropharmacology'.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  FRET; Fluorescent ligands; GPCR oligomerization; Purinergic receptors

Mesh:

Substances:

Year:  2015        PMID: 25890205      PMCID: PMC4608850          DOI: 10.1016/j.neuropharm.2015.04.001

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  65 in total

Review 1.  Principles: a model for the allosteric interactions between ligand binding sites within a dimeric GPCR.

Authors:  Thierry Durroux
Journal:  Trends Pharmacol Sci       Date:  2005-07       Impact factor: 14.819

2.  Purinergic receptors.

Authors:  G Burnstock
Journal:  J Theor Biol       Date:  1976-10-21       Impact factor: 2.691

3.  The synthesis and biological activity of four novel fluorescent vasopressin analogs.

Authors:  W H Lutz; J M Londowski; R Kumar
Journal:  J Biol Chem       Date:  1990-03-15       Impact factor: 5.157

Review 4.  Radioligand binding methods: practical guide and tips.

Authors:  D B Bylund; M L Toews
Journal:  Am J Physiol       Date:  1993-11

5.  Allosteric interactions across native adenosine-A3 receptor homodimers: quantification using single-cell ligand-binding kinetics.

Authors:  Lauren T May; Lloyd J Bridge; Leigh A Stoddart; Stephen J Briddon; Stephen J Hill
Journal:  FASEB J       Date:  2011-06-29       Impact factor: 5.191

6.  Dopamine D(2) receptor-mediated modulation of adenosine A(2A) receptor agonist binding within the A(2A)R/D(2)R oligomer framework.

Authors:  Víctor Fernández-Dueñas; Maricel Gómez-Soler; Xavier Morató; Fabiana Núñez; Arijit Das; T Santhosh Kumar; Serge Jaumà; Kenneth A Jacobson; Francisco Ciruela
Journal:  Neurochem Int       Date:  2013-04-23       Impact factor: 3.921

7.  Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis.

Authors:  Sonia Terrillon; Thierry Durroux; Bernard Mouillac; Andreas Breit; Mohammed A Ayoub; Magali Taulan; Ralf Jockers; Claude Barberis; Michel Bouvier
Journal:  Mol Endocrinol       Date:  2002-12-23

8.  Interactions among adenosine deaminase, adenosine A(1) receptors and dopamine D(1) receptors in stably cotransfected fibroblast cells and neurons.

Authors:  M Torvinen; S Ginés; J Hillion; S Latini; M Canals; F Ciruela; F Bordoni; W Staines; F Pedata; L F Agnati; C Lluis; R Franco; S Ferré; K Fuxe
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

9.  Untangling dopamine-adenosine receptor-receptor assembly in experimental parkinsonism in rats.

Authors:  Víctor Fernández-Dueñas; Jaume J Taura; Martin Cottet; Maricel Gómez-Soler; Marc López-Cano; Catherine Ledent; Masahiko Watanabe; Eric Trinquet; Jean-Philippe Pin; Rafael Luján; Thierry Durroux; Francisco Ciruela
Journal:  Dis Model Mech       Date:  2014-11-14       Impact factor: 5.758

10.  Kinetic analysis of antagonist-occupied adenosine-A3 receptors within membrane microdomains of individual cells provides evidence of receptor dimerization and allosterism.

Authors:  Ross Corriden; Laura E Kilpatrick; Barrie Kellam; Stephen J Briddon; Stephen J Hill
Journal:  FASEB J       Date:  2014-06-26       Impact factor: 5.191

View more
  6 in total

1.  Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines to develop functionalized ligands to target adenosine receptors: fluorescent ligands as an example.

Authors:  Stephanie Federico; Enrico Margiotta; Silvia Paoletta; Sonja Kachler; Karl-Norbert Klotz; Kenneth A Jacobson; Giorgia Pastorin; Stefano Moro; Giampiero Spalluto
Journal:  Medchemcomm       Date:  2019-02-18       Impact factor: 3.597

2.  Conjugable A3 adenosine receptor antagonists for the development of functionalized ligands and their use in fluorescent probes.

Authors:  Stephanie Federico; Enrico Margiotta; Stefano Moro; Eszter Kozma; Zhan-Guo Gao; Kenneth A Jacobson; Giampiero Spalluto
Journal:  Eur J Med Chem       Date:  2019-11-22       Impact factor: 6.514

3.  Nucleoside 5'-O-monophosphorothioates as modulators of the P2Y14 receptor and mast cell degranulation.

Authors:  Edyta Gendaszewska-Darmach; Edyta Węgłowska; Aurelia Walczak-Drzewiecka; Kaja Karaś
Journal:  Oncotarget       Date:  2016-10-25

4.  Bitopic fluorescent antagonists of the A2A adenosine receptor based on pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine functionalized congeners.

Authors:  Romain Duroux; Antonella Ciancetta; Philip Mannes; Jinha Yu; Shireesha Boyapati; Elizabeth Gizewski; Said Yous; Francisco Ciruela; John A Auchampach; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Medchemcomm       Date:  2017-06-22       Impact factor: 3.597

Review 5.  Chemical Probes for the Adenosine Receptors.

Authors:  Stephanie Federico; Lucia Lassiani; Giampiero Spalluto
Journal:  Pharmaceuticals (Basel)       Date:  2019-11-12

Review 6.  Purinergic Signaling in the Pathophysiology and Treatment of Huntington's Disease.

Authors:  Melissa Talita Wiprich; Carla Denise Bonan
Journal:  Front Neurosci       Date:  2021-07-01       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.